Heart rate variability in patients with ankylosing spondilitis (Bekhterev's disease)

Terapevticheskii Arkhiv

Volumn 81, Issue 6, 2009, Pages 56-62

  Poddubny, D A ^a   Gaidukova, I Z ^b   Rebrov, A P ^a  

^a SARATOV STATE MEDICAL UNIVERSITY   (Russian Federation)

^b Saratov Region Government   (Russian Federation)

Author keywords

Ankylosing spondilitis; Heart rate variability

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; HEART RATE; HUMAN; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; C-REACTIVE PROTEIN; FIBRINOGEN; HEART RATE; HUMANS; MALE; SPONDYLITIS, ANKYLOSING;

EID: 70149085787     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Braun J., Sieper J. Ankylosing spondylitis. Lancet 2007; 369: 1379-1390. (Pubitemid 46590387)
2. Radford E. P., Doll R, Smith P. G. Mortality among patients with ankylosing spondylitis not given X-ray therapy. N. Engl. J. Med. 1977; 297: 572-576. (Pubitemid 8197336)
3. Lehtinen K. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann. Rheum. Dis. 1993; 52: 174-176. (Pubitemid 23094303)
4. Del Rincon I. D., Williams K., Stern M. P. et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthr. and Rheum. 2001; 44: 2737-2745. (Pubitemid 34016192)
5. Manzi S., Meilahn E. N., Rairie J. E. et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Fram-ingham Study. Am. J. Epidemiol. 1997; 145: 408-415. (Pubitemid 27084212)
6. Sattar N., McCarey D. W., Capell H., Mclnnes I. B. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 2003: 108: 2957-2963. (Pubitemid 37553561)
7. Divecha H., Sattar N., Rumley A. et al. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation. Clin. Sci. (Lond.) 2005; 109: 171-176. (Pubitemid 41117300)
8. Sari I., Okan T., Akar S. et al. Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology (Oxford) 2006; 45: 283-286. (Pubitemid 43372841)
9. Sajadieh A., Nielsen O. W., Rasmussen V. et al. Increased heart rate and reduced heartrate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur. Heart J. 2004; 25: 363-370. (Pubitemid 38391517)
10. Sloan R. P., McCreath H., Tracey K. J. et al. RR interval variability is inversely related to inflammatory markers: the CAR-DIA study. Mol. Med. 2007; 13: 178-184. (Pubitemid 46944960)
11. Madsen T., Christensen J. H., Toft E., Schmidt E. B. C-reactive protein is associated with heart rate variability. Ann. Noninvasive Electrocardiol. 2007; 12: 216-222. (Pubitemid 47037950)
12. Lampert R., Bremner J. D., Su S. et al. Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. Am. Heart J. 2008; 156: 751-757.
13. Tsuji H., Larson M. G., Venditti F. J., Jr. et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996; 94: 2850-2855. (Pubitemid 26411751)
14. de Bruyne M. C, Kors J. A., Hoes A. W. et al. Both decreased and increased heart rate variability on the standard 10-second electrocardiogram predict cardiac mortality in the elderly: the Rotterdam Study. Am. J. Epidemiol. 1999; 150: 1282-1288.
15. Dekker J. M., Crow R. S., Folsom A. R. et al. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis Risk In Communities. Circulation 2000; 102: 1239-1244.
16. Sajadieh A., Nielsen O. W., Rasmussen V. et al. C-reactive protein, heart rate variability and prognosis in community subjects with no apparent heart disease. J. Intern. Med. 2006; 260: 377-387. (Pubitemid 44370911)
17. Yildirir A., Aksoyek S., Calguneri M. et al. No evidence of cardiac autonomic involvement in ankylosing spondylitis, as assessed by heart rate variability. Clin. Rheumatol. 2001; 20: 185-188. (Pubitemid 32586562)
18. Kazmierczak J., Peregud-Pogorzelska Af., Biernawsko J. et al. Cardiac arrhythmias and conduction disturbances in patients with ankylosing spondylitis. Angiology 2007; 58: 751-756.
19. Borman P., Gokoglu F, Kocaoglu S., Yorgancioglu Z. R. The autonomic dysfunction in patients with ankylosing spondylitis: a clinical and electrophysiological study. Clin. Rheumatol 2008; 27: 1267-1273.
20. van der Linden S., Valkenburg H. A., Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthr. and Rheum 1984; 27: 361-368. (Pubitemid 14134775)
21. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996; 93: 1043-1065.
22. Mallioni A., Pagani M., Lombardi F., Cerutti S. Cardiovascular flelltlegulatlonexpioye in the frequency domain. Circulation 1991; 84; 482-492.
23. Lahiri M. K., Kannankeril P. J., Goldberger I. J. Assessment of autonornic function in cardiovascular disease: physiological basis and prognostic implications. J. Am. Coil. Cardiol. 2008; 51: 1725-1733. (Pubitemid 351608496)